MA/MS in Biomedical Sciences
Amsterdam, North Holland, Netherlands•QS 2027 #185 =
Official program page (opens in a new tab)
At Vrije Universiteit Amsterdam in Amsterdam, Netherlands, MA/MS in Biomedical Sciences is offered as a master's degree in Medicine & Health programme. The programme runs for 2 years. It carries 120.0 credits (ECTS). Teaching is in English. Tuition is EUR 2,694 per year for local students. The next intake is Sep 2027, starting September 1, 2027.
At a glance
Information for the 2027/28 academic year · Last reviewed June 2026 ·
Program details
Overview
Do you want to combine human biology with molecular biology? Or learn about the other possibilities of biomedical sciences after a year of research? This master's programme will offer you just that!
While pursuing a Master's degree in Biomedical Sciences you can opt to study a combination of different specialisations. The research specialisations will enable you to embark on a career in research. In the second year you decide on your profile, either with a focus on research or more into biomedical related specialisations. These will enable you to work in professions like policy officer, sciencific journalism or advisor, and the education specialisation (only in Dutch) will enable you to teach at pre-university or higher vocational education level.
Requirements
Upcoming Intakes
About Vrije Universiteit Amsterdam
“Is verder kijken”
View the full Vrije Universiteit Amsterdam profile
Similar programs in Netherlands
More programs at Vrije Universiteit Amsterdam
Other universities in Netherlands
Frequently asked questions
Vrije Universiteit Amsterdam awards a Master's Degree in the field of Medicine & Health on completion of this programme.
The programme runs for 2 years.
Tuition is EUR 2,694 per year for local students.
The programme is taught in English.
The next intake is Sep 2027, starting September 1, 2027.
Studying in Netherlands: guides and resources
Spotted something outdated or missing?
Help us keep this page accurate — it takes about 30 seconds.